Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Irving

Showing results (461-470 of 563) with videos related to

Pageof 57
Sort By:
Gastroenterology|June 20, 2017
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled TrialHeidi Maria Staudacher, Miranda C E Lomer, Freda M Farquharson, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factorsM G Ward, B Warner, N Unsworth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2011
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potentialDeena L Gibbons, Lucie Abeler-Dörner, Tim Raine, et al.
Diabetes Care|March 4, 2008
Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5)David C Ziemer, Paul Kolm, William S Weintraub, et al.
Gut|January 13, 2022
Establishment of a validated central reading system for ileocolonoscopy in an academic settingTim Raine, Holly Pavey, Wendi Qian, et al.
Neurogastroenterology and Motility|August 25, 2021
Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndromeHeidi M Staudacher, Megan Rossi, Thomas Kaminski, et al.
BMJ Open Gastroenterology|September 1, 2025
Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis from the ELEVATE UC clinical programmeMaría Chaparro, Remo Panaccione, Bruce E Sands, et al.
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Physical Chemistry Chemical Physics : PCCP|March 27, 2020
Exploring the origins of crystallisation kinetics in hierarchical materials using in situ X-ray diffraction and pair distribution function analysisMatthew E Potter, Mark E Light, Daniel J M Irving, et al.
The Journal of Biological Chemistry|January 24, 2019
The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surfaceJoseph M Schrader, Craig M Irving, J Christopher Octeau, et al.
Pageof 57

Showing results (461-470 of 563) with videos related to

Sort By:
Pageof 57
Gastroenterology|June 20, 2017
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled TrialHeidi Maria Staudacher, Miranda C E Lomer, Freda M Farquharson, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factorsM G Ward, B Warner, N Unsworth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2011
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potentialDeena L Gibbons, Lucie Abeler-Dörner, Tim Raine, et al.
Diabetes Care|March 4, 2008
Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5)David C Ziemer, Paul Kolm, William S Weintraub, et al.
Gut|January 13, 2022
Establishment of a validated central reading system for ileocolonoscopy in an academic settingTim Raine, Holly Pavey, Wendi Qian, et al.
Neurogastroenterology and Motility|August 25, 2021
Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndromeHeidi M Staudacher, Megan Rossi, Thomas Kaminski, et al.
BMJ Open Gastroenterology|September 1, 2025
Etrasimod for the symptomatic relief of ulcerative colitis: a post-hoc analysis from the ELEVATE UC clinical programmeMaría Chaparro, Remo Panaccione, Bruce E Sands, et al.
Frontline Gastroenterology|May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal responseMark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Physical Chemistry Chemical Physics : PCCP|March 27, 2020
Exploring the origins of crystallisation kinetics in hierarchical materials using in situ X-ray diffraction and pair distribution function analysisMatthew E Potter, Mark E Light, Daniel J M Irving, et al.
The Journal of Biological Chemistry|January 24, 2019
The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surfaceJoseph M Schrader, Craig M Irving, J Christopher Octeau, et al.
Pageof 57